Nueterra Capital is a Midwest-based venture capital firm specializing in early-stage healthcare and technology companies poised for rapid growth.
Our primary focus is on innovative companies located within U.S. Emerging Markets seeking to address inefficiencies in the administration, diagnosis, and delivery of healthcare.
Nueterra Capital has deployed over $850 million across various healthcare verticals, creating $4.5 billion in value and distributing $3 billion to investors. Our latest healthcare venture fund has generated a gross IRR of 31%, including one portfolio company valued at over $1 billion.
Our team brings more than 25 years of healthcare experience derived from the operations and management of over 150 surgery centers nationwide. This experience positions us favorably to identify administrative and clinical friction points that can be alleviated by software and technology.
We leverage our existing portfolio of operating companies to mitigate investment risk and enhance deal sourcing. This is achieved by offering healthcare founders the opportunity to pilot innovative solutions within our facilities, thereby establishing a valuable feedback loop that strengthens our diligence process and provides a competitive edge in deal sourcing.
Years of Operating History
Dedicated Professionals
Total Capital Distributed
Total Invested Capital
Total Value Created
Portfolio Exits